Analystreport

Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) had its price target lowered by analysts at Royal Bank of Canada from $76.00 to $65.00. They now have an "outperform" rat

Ionis Pharmaceuticals, Inc.  (IONS) 
Last ionis pharmaceuticals, inc. earnings: 2/26 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: ionispharma.com